Open original FDA record ↗Recall record
- FDA identifier
- Z-0545-2022
- Company in FDA record
- Immuno-Mycologics, Inc
- FDA record creation date
- Jan 31, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The firm found immunoassay products used to detect cryptococcal antigen in serum and cerebrospinal fluid to have reduced specificity (90% now versus 99% before). As a result, a small number of samples with positive test results may be false positives, which may cause some patients to initiate unnecessary anti-fungal therapy. Samples with negative test results are NOT affected.
Source facts
- Action
- Customers who received product were contacted via letter Urgent: Medical Device Recall, Cryptococcal Antigen Lateral Flow Assay, dated January 3, 2022, beginning January 3, 2022, to locate and immediately destroy their affected devices. A recall notification and response form was attached to the email that is to be completed by the customers and returned to the firm.
- Initiated
- 2022-01-03
- Root cause
- Material/Component Contamination
- Terminated
- 2024-05-15
- Distribution
- US Nationwide distribution in the states of AL, AR, AZ, CA, CO, CT, FL, GA, IL, IN, KY, LA, MA, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NY, OH, OR, PA, RI, SC, TN, TX, UT, VA, WA.
- Recall number
- Z-0545-2022
- Recall status
- Terminated
- CDRH record ID
- 191362
- FDA record created
- 2022-01-31
- Recall event number
- 89370